Seelos Therapeutics, Inc.
SEELDelisted Apr 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001017491
Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Seelos Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +32 vs. Q1 2021
- Shares held
- 40.8M
- +15.8M (+63.3%) vs. Q1 2021
- Total value
- $107.8M
- −$17.0M (−13.6%) vs. Q1 2021
- New holders
- 50
- 26 more added
- Sold out
- 18
- 19 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SEEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 3 | $4.77K |
| Q3 2024 | 15 | $145.2K |
| Q2 2024 | 23 | $129.4K |
| Q1 2024 | 36 | $1.55M |
| Q4 2023 | 39 | $2.48M |
| Q3 2023 | 82 | $7.01M |
| Q2 2023 | 83 | $27.1M |
| Q1 2023 | 80 | $15.1M |
| Q4 2022 | 80 | $15.6M |
| Q3 2022 | 85 | $28.0M |
| Q2 2022 | 86 | $21.3M |
| Q1 2022 | 92 | $33.0M |
| Q4 2021 | 97 | $65.9M |
| Q3 2021 | 110 | $98.2M |
| Q2 2021 | 105 | $107.8M |
| Q1 2021 | 73 | $124.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Seelos Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acuta Capital Partners, LLC | 2,860,000 | $7.55M | 3.23% | +1,140,188+66.3% | Added |
| Woodline Partners LP | 3,044,432 | $8.04M | 0.15% | +2,333,194+328.0% | Added |
| Vanguard Group Inc | 4,800,323 | $12.7M | 0.00% | +1,879,159+64.3% | Added |
| BlackRock Inc. | 5,341,811 | $14.1M | 0.00% | +4,148,748+347.7% | Added |
| TSFG, LLC | 100 | – | – | +100 | New |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −1,446,465−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −611,624−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −609,013−100.0% | Sold out |
| Asymmetry Capital Management, L.P. | 0 | $0 | 0.00% | −440,745−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −109,257−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −31,060−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −25,707−100.0% | Sold out |
| Commerce Bank | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −23,983−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −10,388−100.0% | Sold out |
| Atlas Private Wealth Advisors | 0 | $0 | 0.00% | −4,240−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,839−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| American Portfolios Advisors | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −421−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |